OlarteMoure

The life sciences practice at premier IP firm, OlarteMoure, is ‘among the best in LatAm’, according to sources. Certainly, its cross-border credentials are evidenced by the fact that several of its major multinational pharmaceutical clients use its patent services in up to 18 countries across the region. Alongside its strength in patents, the group also shines in regulatory work, where it advises on domestic, US, EU and wider Latin American regulations concerning local incorporations, marketing authorisation (MA) approvals and pricing issues, among other matters. Co-founding partner, Carlos Olarte, is also a biomedical and mechanical engineer and leverages over three decades of experience in patent drafting and portfolio management, with a focus on the biopharmaceutical and telecoms sectors. Olarte is additionally a key contact for life sciences regulation and recently paired up with next-generation life sciences specialist, Alexander Agudelo, to advise Vertex Pharmaceuticals on regulatory compliance, market access and distribution contracts, among other issues. The team further benefits from the experience of two newly promoted (October 2023) partners: patent head Mónica Guevara is noted for her experience across the full life cycle of patent law, while compliance director Catalina Jimenez Abadía specialises in advising multinational life science companies on compliance and risk mitigation concerning transnational anti-corruption legislation. Key non-partners include seasoned of counsel, Ana Frieri, and patent litigation director Liliana Galindo.